Nanoparticle MRI research toolbox
FeraSpin™ XS MRI agent (1 x 5 injections): 130 - 095 - 140
FeraSpin™ XS MRI agent (5 x 5 injections): 130 - 095 - 141
FeraSpin™ S MRI agent (1 x 5 injections): 130 - 095 - 166
FeraSpin™ S MRI agent (5 x 5 injections): 130 - 095 - 167
FeraSpin™ M MRI agent (1 x 5 injections): 130 - 095 - 168
FeraSpin™ M MRI agent (5 x 5 injections): 130 - 095 - 169
FeraSpin™ L MRI agent (1 x 5 injections): 130 - 095 - 170
FeraSpin™ L MRI agent (5 x 5 injections): 130 - 095 - 171
FeraSpin™ XL MRI agent (1 x 5 injections): 130 - 095 - 172
FeraSpin™ XL MRI agent (5 x 5 injections): 130 - 095 - 173
FeraSpin™ XXL MRI agent (1 x 5 injections): 130 - 095 - 174
FeraSpin™ XXL MRI agent (5 x 5 injections): 130 - 095 - 175
The FeraSpin™ Series is a product family of six size-selected agents derived from FeraSpin R:
FeraSpin XS to FeraSpin XXL. The identical chemical composition and ultra-narrow size distribution of these fractions allows for fine-tuning of the pharmacologic profile according to your own innovative applications.
The unique series of size-selected superparamagnetic iron oxide nanoparticles:
- Is analogous to human clinical agents
- Encompasses particle fractions ranging from ultrasmall to a large size
- Offers tunable T1 and T2/T2* relaxation properties
- The FeraSpin Series is Viscover's unique and powerful toolbox for nanoparticle MRI research
Apply the FeraSpin Series to
- Adjust your unique MR contrast agent for extended circulation, or macrophage and organ-specific uptake by the liver and spleen
- Perform effective experiments in MR physics, sequence development and nanoparticle physiology
Characteristics of the FeraSpin Series with respect to particle size
|FeraSpin™|| Mean particle size |
| Relaxivity r2/r1 |
(in water 37 °C, 1.41 T )
|XS||10 – 20 nm||3 - 5|
|S||20 – 30 nm||5 - 9|
|M||30 – 40 nm||9 - 22|
|L||40 – 50 nm||22 - 32|
|XL||50 – 60 nm||32 - 39|
|XXL||60 – 70 nm||39 - 46|
- Lohrke, J. et al. (2008) Characterization of superparamagnetic iron oxide nanoparticles by asymmetrical flow-field-flow-fractionation. Nanomedicine 3: 437-452.
- Allkemper, T. et al. (2002) Contrast-enhanced blood-pool MR angiography with optimized iron oxides: effect of size and dose on vascular contrast enhancement in rabbits. Radiology 223: 432-438.
- Tsuda, N. et al. (2005) Potential of superparamagnetic iron oxide in the differential diagnosis of metastasis and inflammation in bone marrow: experimental study. Invest. Radiol. 40: 676-681.
- Metz, S. et al. (2004) Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro. Eur. Radiol. 14: 1851-1858.
- Ludwig, F. et al. (2012) Optimization of Magnetic Nanoparticles for Magnetic Particle Imaging. IEEE Transactions on Magnetics. 48(11): 3780-3783.
- Data Sheet FeraSpin XS
- Data Sheet FeraSpin S
- Data Sheet FeraSpin M
- Data Sheet FeraSpin L
- Data Sheet FeraSpin XL
- Data Sheet FeraSpin XXL
- Poster: New Perspectives for MPI: A Toolbox for Tracer Research
- Poster: The Potential of Clustered Core Magnetic Particles for MPI
- Poster: Bacterial Magnetosomes as a new type of Biogenic MPI Tracer